Medications for Hemochromatosis
10 results
Deferasirox (deferasirox)
(Deferasirox)Teva Pharmaceuticals Inc
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.
Deferasirox (deferasirox)
(DEFERASIROX)Alembic Pharmaceuticals Limited
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients aged 2 years and older. The safety and efficacy of this drug with other iron chelation therapies are not established.
Deferasirox (deferasirox)
(deferasirox)Bionpharma Inc.
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.
Deferasirox (deferasirox)
(Deferasirox)Ascend Laboratories, LLC
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
Deferasirox (deferasirox)
(DEFERASIROX)Zydus Pharmaceuticals USA Inc.
Usage: Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration and serum ferritin levels.
Deferasirox (deferasirox)
(Deferasirox)Actavis Pharma, Inc.
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.
Deferasirox oral granules (deferasirox)
(deferasirox)EPIC PHARMA, LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.
Deferasorox (deferasirox)
(Deferasirox)MSN LABORATORIES PRIVATE LIMITED
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.
Deferasorox (deferasirox)
(Deferasirox)Novadoz Pharmaceuticals LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, as well as for those aged 10 and older with non-transfusion dependent thalassemia syndromes, if specific liver iron concentration and serum ferritin levels are met.
Jadenu (deferasirox)
(deferasirox)Novartis Pharmaceuticals Corporation
Usage: JADENU is indicated for treating chronic iron overload from blood transfusions in patients aged 2 and older, and for chronic iron overload in patients aged 10 and older with non-transfusion-dependent thalassemia syndromes meeting specific liver iron and serum ferritin criteria.